TR200102647T2 - Doğurganlığı geliştirmeye mahsus bileşimler - Google Patents
Doğurganlığı geliştirmeye mahsus bileşimlerInfo
- Publication number
- TR200102647T2 TR200102647T2 TR2001/02647T TR200102647T TR200102647T2 TR 200102647 T2 TR200102647 T2 TR 200102647T2 TR 2001/02647 T TR2001/02647 T TR 2001/02647T TR 200102647 T TR200102647 T TR 200102647T TR 200102647 T2 TR200102647 T2 TR 200102647T2
- Authority
- TR
- Turkey
- Prior art keywords
- compositions
- improving fertility
- sterility
- inhibitors
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Dipeptidil peptidaz IV inhibitörleri ve bu inhibitörleri ihtiva eden farmasötik bilesimler kisirlik tedavisinde ve bilhassa polikistik over sendromuna bagli olarak insan disisinde görülen kisirlik tedavisinde faydalidirlar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906714.2A GB9906714D0 (en) | 1999-03-23 | 1999-03-23 | Compositions for improving fertility |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102647T2 true TR200102647T2 (tr) | 2002-01-21 |
Family
ID=10850229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02647T TR200102647T2 (tr) | 1999-03-23 | 2000-03-21 | Doğurganlığı geliştirmeye mahsus bileşimler |
Country Status (29)
Country | Link |
---|---|
US (1) | US7115650B1 (tr) |
EP (1) | EP1162969B1 (tr) |
JP (1) | JP2002539243A (tr) |
KR (1) | KR100689951B1 (tr) |
CN (1) | CN1196483C (tr) |
AR (1) | AR023129A1 (tr) |
AT (1) | ATE328594T1 (tr) |
AU (1) | AU765912B2 (tr) |
CA (1) | CA2366911C (tr) |
CZ (1) | CZ20013410A3 (tr) |
DE (1) | DE60028552T2 (tr) |
DK (1) | DK1162969T3 (tr) |
ES (1) | ES2265918T3 (tr) |
GB (1) | GB9906714D0 (tr) |
HK (1) | HK1046647B (tr) |
HU (1) | HUP0200410A3 (tr) |
IL (1) | IL145569A0 (tr) |
MX (1) | MXPA01009612A (tr) |
MY (1) | MY135683A (tr) |
NO (1) | NO20014607L (tr) |
NZ (1) | NZ514449A (tr) |
PL (1) | PL195779B1 (tr) |
PT (1) | PT1162969E (tr) |
RU (1) | RU2246944C2 (tr) |
TR (1) | TR200102647T2 (tr) |
TW (1) | TWI244920B (tr) |
UA (1) | UA77644C2 (tr) |
WO (1) | WO2000056296A2 (tr) |
ZA (1) | ZA200108083B (tr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6979697B1 (en) | 1998-08-21 | 2005-12-27 | Point Therapeutics, Inc. | Regulation of substrate activity |
GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
US6512120B1 (en) | 2001-03-12 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Methods for the synthesis of densely functionalized pyrrolidine intermediates |
GB0109146D0 (en) * | 2001-04-11 | 2001-05-30 | Ferring Bv | Treatment of type 2 diabetes |
DE60221983T2 (de) | 2001-06-27 | 2008-05-15 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidyl-peptidase inhibitoren |
DE60222667T2 (de) | 2001-06-27 | 2008-07-17 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren |
JP4300108B2 (ja) | 2001-06-27 | 2009-07-22 | スミスクライン ビーチャム コーポレーション | ジペプチジルペプチダーゼ阻害剤としてのピロリジン類 |
US7074798B2 (en) | 2002-02-25 | 2006-07-11 | Eisai Co., Ltd | Xanthine derivative and DPPIV inhibitor |
US6710040B1 (en) | 2002-06-04 | 2004-03-23 | Pfizer Inc. | Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
PL374007A1 (en) | 2002-06-06 | 2005-09-19 | Eisai Co, Ltd. | Novel fused imidazole derivative |
WO2005026114A1 (en) * | 2003-09-17 | 2005-03-24 | Pfizer Inc. | Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
NZ566799A (en) | 2005-09-14 | 2011-04-29 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
WO2007035629A2 (en) | 2005-09-16 | 2007-03-29 | Takeda Pharmaceutical Company Limited | Process for the preparation of pyrimidinedione derivatives |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US8247438B2 (en) | 2008-02-27 | 2012-08-21 | Neuropill, Inc. | Methods for treating schizophrenia |
EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
EP2556056A1 (en) | 2010-04-06 | 2013-02-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
EA201791982A1 (ru) | 2015-03-09 | 2020-02-17 | Интекрин Терапьютикс, Инк. | Способы лечения неалкогольной жировой болезни печени и/или липодистрофии |
CA3036202A1 (en) | 2016-09-07 | 2018-03-15 | Trustees Of Tufts College | Combination therapies using immuno-dash inhibitors and pge2 antagonists |
CN110996951A (zh) | 2017-04-03 | 2020-04-10 | 科赫罗斯生物科学股份有限公司 | 治疗进行性核上性***PPARγ激动剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05508624A (ja) | 1990-04-14 | 1993-12-02 | ニュー イングランド メデカル センター ホスピタルズ インク | ジペプチジル―アミノベプチダーゼ・4型の阻害剤 |
DK0610317T3 (da) | 1991-10-22 | 2001-02-19 | New England Medical Center Inc | Inhibitorer af dipeptidyl-aminopeptidase type IV |
IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US5952301A (en) | 1996-12-10 | 1999-09-14 | 1149336 Ontario Inc. | Compositions and methods for enhancing intestinal function |
-
1999
- 1999-03-23 GB GBGB9906714.2A patent/GB9906714D0/en not_active Ceased
-
2000
- 2000-03-21 MY MYPI20001122A patent/MY135683A/en unknown
- 2000-03-21 WO PCT/IB2000/000382 patent/WO2000056296A2/en not_active Application Discontinuation
- 2000-03-21 DK DK00911186T patent/DK1162969T3/da active
- 2000-03-21 IL IL14556900A patent/IL145569A0/xx unknown
- 2000-03-21 JP JP2000606201A patent/JP2002539243A/ja not_active Withdrawn
- 2000-03-21 CZ CZ20013410A patent/CZ20013410A3/cs unknown
- 2000-03-21 CA CA002366911A patent/CA2366911C/en not_active Expired - Fee Related
- 2000-03-21 HU HU0200410A patent/HUP0200410A3/hu unknown
- 2000-03-21 ES ES00911186T patent/ES2265918T3/es not_active Expired - Lifetime
- 2000-03-21 MX MXPA01009612A patent/MXPA01009612A/es not_active Application Discontinuation
- 2000-03-21 AT AT00911186T patent/ATE328594T1/de not_active IP Right Cessation
- 2000-03-21 KR KR1020017012144A patent/KR100689951B1/ko not_active IP Right Cessation
- 2000-03-21 EP EP00911186A patent/EP1162969B1/en not_active Expired - Lifetime
- 2000-03-21 US US09/937,032 patent/US7115650B1/en not_active Expired - Fee Related
- 2000-03-21 CN CNB008053243A patent/CN1196483C/zh not_active Expired - Fee Related
- 2000-03-21 DE DE60028552T patent/DE60028552T2/de not_active Expired - Lifetime
- 2000-03-21 AU AU33177/00A patent/AU765912B2/en not_active Ceased
- 2000-03-21 NZ NZ514449A patent/NZ514449A/xx unknown
- 2000-03-21 PL PL00350797A patent/PL195779B1/pl not_active IP Right Cessation
- 2000-03-21 RU RU2001128507/15A patent/RU2246944C2/ru not_active IP Right Cessation
- 2000-03-21 PT PT00911186T patent/PT1162969E/pt unknown
- 2000-03-21 TR TR2001/02647T patent/TR200102647T2/tr unknown
- 2000-03-21 UA UA2001096488A patent/UA77644C2/uk unknown
- 2000-03-22 AR ARP000101280A patent/AR023129A1/es unknown
- 2000-03-23 TW TW089105322A patent/TWI244920B/zh not_active IP Right Cessation
-
2001
- 2001-09-21 NO NO20014607A patent/NO20014607L/no not_active Application Discontinuation
- 2001-10-02 ZA ZA200108083A patent/ZA200108083B/xx unknown
-
2002
- 2002-11-19 HK HK02108361.2A patent/HK1046647B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102647T2 (tr) | Doğurganlığı geliştirmeye mahsus bileşimler | |
IL139862A0 (en) | Thiazolidine or pyrrolidine derivatives as dipeptidyl peptidase iv effectors and pharmaceutical compositions containing the same | |
EA200501805A1 (ru) | Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы | |
ATE395912T1 (de) | Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes | |
NO20052380L (no) | Beta-amino-heterosykliske dipeptidylpeptidaseinhibitorer for behandling og forhindring av diabetes | |
HK1024865A1 (en) | Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies | |
ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
EP1624874A4 (en) | 3-AMINO-4-PHENYLBUTANOIC ACID DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IN THE TREATMENT OR PREVENTION OF DIABETES | |
IS7817A (is) | Fenýlalanín afleiður sem dípeptidýl peptíðasa hindrar til að meðhöndla eða fyrirbyggja sykursýki. | |
EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
SE0102438D0 (sv) | New compounds | |
TR200103428T2 (tr) | IMPDH enzim inhibitörleri. | |
SE0102315D0 (sv) | Compounds | |
DK0915898T3 (da) | Krystalform I af clarithromycin | |
TR200101793T2 (tr) | CCR5 modülatörleri olarak azabisikloalkanlar | |
ATE234282T1 (de) | Polymorphe verbindungen | |
EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
MX9306295A (es) | Composiciones farmaceuticas para tratar sintomas de resfriado. | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
FI964772A0 (fi) | (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa | |
DE60313004D1 (de) | Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination | |
ATE243196T1 (de) | Piperidine und pyrrolidine | |
DE69033970T2 (de) | Huperzin a analoge verbindungen | |
ATE308328T1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
EP1178796A4 (en) | AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE |